XML 119 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance at Apr. 30, 2021 $ 41,241 $ 6,915 $ 3,807 $ (53) $ 34,149 $ (3,577)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (1,345)       (1,345)  
Other comprehensive loss (76)         (76)
Stock-based compensation 238 67 171      
Ending balance at Jul. 31, 2021 40,058 6,982 3,978 (53) 32,804 (3,653)
Beginning balance at Apr. 30, 2021 41,241 6,915 3,807 (53) 34,149 (3,577)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (5,764)          
Other comprehensive loss (107)          
Ending balance at Jan. 31, 2022 35,847 6,983 4,216 (53) 28,385 (3,684)
Beginning balance at Jul. 31, 2021 40,058 6,982 3,978 (53) 32,804 (3,653)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (3,100)       (3,100)  
Other comprehensive loss (83)         (83)
Stock-based compensation 130 1 129      
Ending balance at Oct. 31, 2021 37,005 6,983 4,107 (53) 29,704 (3,736)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (1,319)       (1,319)  
Other comprehensive loss 52         52
Stock-based compensation 109 0 109      
Ending balance at Jan. 31, 2022 35,847 6,983 4,216 (53) 28,385 (3,684)
Beginning balance at Apr. 30, 2022 35,694 6,983 4,483 (53) 28,023 (3,742)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (747)       (747)  
Other comprehensive loss (224)         (224)
Stock-based compensation (37) 97 (134)      
Ending balance at Jul. 31, 2022 34,686 7,080 4,349 (53) 27,276 (3,966)
Beginning balance at Apr. 30, 2022 35,694 6,983 4,483 (53) 28,023 (3,742)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (267)          
Other comprehensive loss (567)          
Ending balance at Jan. 31, 2023 35,351 7,084 4,873 (53) 27,756 (4,309)
Beginning balance at Jul. 31, 2022 34,686 7,080 4,349 (53) 27,276 (3,966)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation (243)       (243)  
Other comprehensive loss (237)         (237)
Stock-based compensation 196 4 192      
Ending balance at Oct. 31, 2022 34,402 7,084 4,541 (53) 27,033 (4,203)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation 723       723  
Other comprehensive loss (106)         (106)
Stock-based compensation 332   332      
Ending balance at Jan. 31, 2023 $ 35,351 $ 7,084 $ 4,873 $ (53) $ 27,756 $ (4,309)